VIPR Corp. (VIPV)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
VIPR Corp. (VIPV) trades at $0.00 with AI Score 48/100 (Grade C). VIPR Corp. operates in the strategic nutraceutical and nutraceutical-related products sector, focusing on personal consumption, apparel, and home applications. Market cap: $6,069, Sector: Basic materials.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for VIPV: VIPV does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates VIPV against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
VIPV: the 1 perspectives are evenly split.
How is this calculated? →VIPR Corp. (VIPV) Materials & Commodity Exposure
VIPR Corp., operating in the basic materials sector, focuses on acquiring, developing, and marketing strategic nutraceutical and nutraceutical-related products. Catering to personal consumption, apparel, and home applications, the company faces challenges typical of small, OTC-listed entities in a competitive market.
What Is the Investment Thesis for VIPV?
VIPR Corp. presents a speculative investment opportunity, given its small market capitalization and OTC listing. Key value drivers include successful acquisition and development of marketable nutraceutical products. Growth catalysts hinge on effective marketing strategies and expansion into new application areas within personal consumption, apparel, and home applications. However, potential risks include limited financial resources, intense competition, and the inherent volatility associated with OTC-listed stocks. Investors should carefully consider the company's financial position, market execution, and the regulatory landscape governing nutraceutical products. The company's P/E ratio is -0.01 and the Beta is 4.42 as of March 17, 2026.
Based on FMP financials and quantitative analysis
VIPV Key Highlights
- VIPR Corp. focuses on the acquisition, development, and marketing of strategic nutraceutical and nutraceutical related products.
- The company targets applications in personal consumption, apparel, and home applications.
- VIPR Corp. was formerly known as S2C Global Systems Inc. and changed its name in August 2014.
- The company is based in Scottsdale, Arizona.
- VIPR Corp. has a market capitalization of 6K as of March 17, 2026.
Who Are VIPV's Competitors?
VIPV is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| MTA Metalla Royalty & Streaming Ltd. acquires and manages precious metal royalties and streams, focusing on gold and silver. The company | $7.48 | -2.09% | $698.95M | 68 |
| EMPYF Empress Royalty Corp. | $0.61 | -9.31% | $80.81M | 66 |
| ARIS Aris Mining Corporation | $15.89 | -0.69% | $3.28B | 65 |
| BVN Compañía de Minas Buenaventura S.A.A. is involved in the exploration, mining development, processing, and trading of precious and base metals. The company | $29.86 | +0.49% | $7.59B | 65 |
| MUX McEwen Mining Inc. | $18.89 | -0.08% | $1.13B | 48 |
| WPGCF West Point Gold Corp. | $1.11 | +9.47% | $116.05M | 48 |
| DNRSF Denarius Metals Corp. | $0.45 | +2.04% | $34.28M | 49 |
| NEWP New Pacific Metals Corp. | $4.33 | +1.29% | $797.74M | 49 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are VIPV's Key Strengths?
- Focus on a growing market segment (nutraceuticals).
- Potential for product innovation.
- Flexibility to adapt to changing consumer preferences.
What Are VIPV's Weaknesses?
- Limited financial resources.
- Small market capitalization.
- OTC listing increases perceived risk.
- Dependence on successful product development and marketing.
What Could Drive VIPV Stock Higher?
- Successful acquisition of new nutraceutical product lines.
- Strategic partnerships with established companies in apparel or home goods.
- Increasing consumer awareness of health and wellness trends.
- Expansion of e-commerce sales channels.
What Are the Key Risks for VIPV?
- Negative return on equity (-0.0%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Limited financial resources to compete with larger players.
- Changing regulatory landscape for nutraceuticals.
- Intense competition in the nutraceuticals market.
- Low liquidity due to OTC listing.
- Economic downturn affecting consumer spending on discretionary items.
What Are the Growth Opportunities for VIPV?
- Expansion into New Product Lines: VIPR Corp. can explore developing new nutraceutical products targeting specific health concerns, such as immune support or cognitive function. The global dietary supplements market is projected to reach $278 billion by 2028, offering a substantial market for targeted nutraceutical products. Successful product launches could significantly increase revenue and market share.
- Strategic Partnerships: Collaborating with established companies in the apparel and home goods sectors could provide VIPR Corp. with access to new distribution channels and customer bases. These partnerships could involve integrating VIPR's nutraceutical products into existing product lines, creating unique value propositions for consumers. Such collaborations can accelerate market penetration and brand recognition.
- E-commerce Expansion: Investing in a robust e-commerce platform and digital marketing strategies can enhance VIPR Corp.'s direct-to-consumer sales. The online channel offers a cost-effective way to reach a wider audience and build brand loyalty. Focusing on targeted advertising and personalized customer experiences can drive online sales growth.
- Geographic Expansion: Exploring opportunities to expand into new geographic markets, particularly in regions with growing health and wellness trends, can drive revenue growth. Conducting market research to identify regions with strong demand for nutraceutical products and adapting product offerings to local preferences can facilitate successful market entry.
- Research and Development: Investing in research and development to identify and validate new nutraceutical ingredients and formulations can create a competitive advantage. Developing proprietary formulations with scientifically proven benefits can differentiate VIPR Corp.'s products and attract health-conscious consumers. This can lead to premium pricing and increased market share.
What Opportunities Does VIPV Have?
- Expansion into new product lines.
- Strategic partnerships with established companies.
- Growth in e-commerce sales.
- Geographic expansion into new markets.
What Threats Does VIPV Face?
- Intense competition from larger players.
- Changing regulatory landscape for nutraceuticals.
- Economic downturn affecting consumer spending.
- Potential for product liability issues.
What Are VIPV's Competitive Advantages?
- Proprietary formulations (if any).
- Strategic partnerships (if any).
- Brand recognition (limited, but potential for growth).
- Focus on niche markets within the nutraceutical space.
What Does VIPV Do?
VIPR Corp., based in Scottsdale, Arizona, operates within the basic materials sector, specifically focusing on strategic nutraceutical and nutraceutical-related products. Founded as S2C Global Systems Inc., the company rebranded to VIPR Corp. in August 2014, signaling a strategic shift towards the nutraceutical market. The company's core business revolves around the acquisition, development, and marketing of these products, targeting applications in personal consumption, apparel, and home goods. VIPR Corp. aims to capitalize on the growing consumer interest in health and wellness products. The company's strategy involves identifying and developing nutraceutical products that can be integrated into various consumer goods. Its small size and focus on niche markets differentiate it from larger players in the broader consumer goods and nutraceutical industries. As of 2026, VIPR Corp. continues to navigate the challenges and opportunities presented by the evolving nutraceutical market, seeking to establish a sustainable presence through strategic product development and marketing initiatives.
What Products and Services Does VIPV Offer?
- Acquires strategic nutraceutical products.
- Develops nutraceutical-related products.
- Markets products for personal consumption.
- Markets products for apparel applications.
- Markets products for home applications.
- Focuses on strategic products.
How Does VIPV Make Money?
- Acquire nutraceutical product rights.
- Develop and formulate products.
- Market and sell products through various channels.
- Generate revenue through product sales.
What Industry Does VIPV Operate In?
VIPR Corp. operates in the nutraceuticals market, a segment of the broader dietary supplements industry. This market is characterized by increasing consumer awareness of health and wellness, driving demand for products with perceived health benefits. The industry is competitive, with numerous players ranging from large multinational corporations to smaller, niche-focused companies. VIPR Corp.'s focus on strategic nutraceutical products places it in a segment that requires innovation and effective marketing to stand out. The company's success depends on its ability to identify and capitalize on emerging trends in consumer health and wellness.
Who Are VIPV's Key Customers?
- Individual consumers seeking health and wellness products.
- Apparel manufacturers integrating nutraceuticals into their products.
- Home goods manufacturers incorporating nutraceuticals into their products.
ROE -0%Key Financial Metrics
Return on equity for VIPR Corp. stands at -0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -0.0%, showing how much profit it generates from its asset base. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value.
VIPR Corp. (VIPV) Valuation Context
Valued at 6K, VIPV is classified as a micro-cap stock. Relative to its peer group, VIPV's quantitative score of 48/100 is below the peer average of 62/100.
Company Profile
VIPR Corp. operates in the Other Precious Metals industry within the Basic Materials sector. It is headquartered in Scottsdale, US. The company is led by CEO Daniel Roth. VIPV has traded publicly since 2005.
F-Score 1/9Financial Health
VIPR Corp.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
VIPV Financials
Bull Case vs Bear Case
Bull Case
- Focus on a growing market segment (nutraceuticals).
- Potential for product innovation.
- Flexibility to adapt to changing consumer preferences.
- Upcoming: Successful acquisition of new nutraceutical product lines.
Bear Case
- Limited financial resources.
- Small market capitalization.
- OTC listing increases perceived risk.
- Dependence on successful product development and marketing.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
VIPV Latest News
No recent news available for VIPV.
VIPV Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VIPV.
Price Targets
Wall Street price target analysis for VIPV.
VIPV MoonshotScore
What does this score mean?
The MoonshotScore rates VIPV's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Daniel Roth
Managing Director
Daniel Roth serves as the managing director of VIPR Corp., overseeing the company's strategic direction and operations. Information on his prior experience and educational background is not available. As managing director, he is responsible for guiding VIPR Corp.'s efforts in the acquisition, development, and marketing of strategic nutraceutical and nutraceutical-related products.
Track Record: Due to limited information, Daniel Roth's specific achievements and strategic decisions at VIPR Corp. cannot be assessed. His tenure and impact on the company's milestones remain unknown.
VIPV OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing securities that are not eligible for OTCQX or OTCQB. Companies in this tier often have limited or no financial disclosure, and may not meet minimum financial standards. Investing in OTC Other stocks carries significant risks due to the lack of transparency and regulatory oversight compared to stocks listed on major exchanges like the NYSE or NASDAQ. These securities are often considered highly speculative.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited or no financial disclosure.
- Low liquidity and high volatility.
- Potential for fraud or manipulation.
- Lack of regulatory oversight.
- Going concern risk.
- Verify the company's registration and legal standing.
- Assess the company's management team and their experience.
- Review any available financial statements, however limited.
- Understand the company's business model and revenue streams.
- Evaluate the competitive landscape and the company's position.
- Assess the potential risks and challenges facing the company.
- Consult with a qualified financial advisor.
- Company has been in operation for several years.
- The company maintains a website and public presence.
- The company has a clear business model.
- The company has a registered address and contact information.
- The company's management team is identifiable.
VIPR Corp. Basic Materials Stock: Key Questions Answered
What does VIPR Corp. do?
VIPR Corp. focuses on the acquisition, development, and marketing of strategic nutraceutical and nutraceutical-related products. Targeting applications in personal consumption, apparel, and home applications, the company aims to capitalize on the growing consumer interest in health and wellness. VIPR Corp. operates by identifying and developing nutraceutical products that can be integrated into various consumer goods, seeking to establish a sustainable presence through strategic product development and marketing initiatives.
What do analysts say about VIPV stock?
As of March 17, 2026, there is no available analyst coverage for VIPV stock. Given its OTC listing and small market capitalization, the stock is unlikely to be actively tracked by major research firms. Investors should rely on their own due diligence and risk assessment when considering an investment in VIPV. Key valuation metrics include revenue growth, gross margin, and cash flow, but the availability of reliable financial data is limited.
What are the main risks for VIPV?
VIPR Corp. faces several risks, including limited financial resources, intense competition in the nutraceuticals market, and the inherent volatility associated with OTC-listed stocks. The company's success depends on its ability to successfully acquire, develop, and market new products, which carries execution risk. Additionally, changes in the regulatory landscape for nutraceuticals could impact the company's operations and profitability. The low liquidity of the stock also poses a risk for investors.
What are the key factors to evaluate for VIPV?
VIPR Corp. (VIPV) holds an AI score of 48/100 (low). Not financial advice.
How frequently does VIPV data refresh on this page?
VIPV prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven VIPV's recent stock price performance?
VIPR Corp. (VIPV) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on a growing market segment (nutraceuticals). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider VIPV overvalued or undervalued right now?
Valuing VIPR Corp. (VIPV) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying VIPV?
Before investing in VIPR Corp. (VIPV), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial information available for VIPR Corp.
- OTC stocks carry higher risks than exchange-listed stocks.
- AI analysis pending for VIPV.